Semaglutide treatment would be cost-effective at an annual price of $7,055 or less for adults with cardiovascular disease.
Most US adults with hypertension had uncontrolled blood pressure, and most of those adults were not taking antihypertensive medication.
Predictive testing and preventative treatment appealed to patients with inflammatory bowel disease and their family members.
Long-term low-dose aspirin use is associated with a significantly reduced risk for colorectal cancer and all-cause mortality among those with IBD.